FGF2 and cancer: The ability of InsP5 to inhibit Akt activation was not limited to cancer cell lines, as this was also observed in PTEN–/– embryonic stem cells [63] and in human umbilical vein endothelial cells stimulated with basic fibroblast growth factor (FGF-2) [64].